METTL3 and prostate carcinoma: Cai et al. found that METTL3 was highly expressed in prostate cancer, where it promoted m6A modification and expression of GLI family zinc finger 1 (GLI1), an important component of the Hedgehog pathway, and regulated the Hedgehog pathway to promote prostate cancer development [130].